Increased Immunoendocrine Cells in Intestinal Mucosa of Postinfectious Irritable Bowel Syndrome Patients 3 Years after Acute Shigella Infection - An Observation in a Small Case Control Study
Open accessAbstract
PURPOSE: Postinfectiously irritable bowel syndrome (PI-IBS) develops in 3-30% of individuals with bacterial gastroenteritis. Recent studies demonstrated increases in inflammatory components in gut mucosa of PI-IBS patients even after complete resolution of infection. We aimed to investigate histological changes in colon and rectum of PI-IBS subjects after long term period of infection. MATERIALS AND METHODS: We recruited PI-IBS subjects who had been diagnosed IBS after complete resolution of enteritis caused by shigellosis outbreak 3 years earlier. We compared unmatched four groups, PI-IBS (n = 4), non PI-IBS (n = 7), D-IBS (n = 7, diarrhea predominant type) and healthy controls (n = 10). All of them underwent colonoscopic biopsy at three areas, including descending colon (DC), sigmoid colon (SC) and rectum, which were assessed for 5-hydroxytryptamine (5-HT)/peptide YY (PYY)-containing enterochromaffin (EC) cell, intraepithelial (IEL) and lamina propria T lymphocyte (CD3), CD8 lymphocytes, mast cells and CD68/calprotectin+ macrophages. RESULTS: All subjects had no structural or gross abnormalities at colonoscopy. In PI-IBS, 5-HT containing EC cells, PYY containing EC cells, IELs, CD3 lymphocytes, CD8 lymphocytes, mast cells, and CD68 + macrophages were increased compared to control (p < 0.05). In D-IBS, PYY containing EC cells, IELs, and CD3 lymphocytes were increased compared to control (p < 0.05). In PI-IBS, 5-HT containing EC cells tended to increase and PYY containing EC cells, CD8 lymphocytes, mast cells, and CD68+ macrophages were increased compared to non PI-IBS (p < 0.05). Calprotectin + marcrophages were decreased in PI-IBS, non PI-IBS and IBS compared to control. CONCLUSION: The immunoendocrine cells were sporadically increased in PI-IBS, non PI-IBS and D-IBS compared with control. Our findings in a very small number of patients suggest that mucosal inflammation may play a role in long-term PI-IBS, and that other sub-groups of IBS and larger scale studies are needed to confirm this observation.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased concentrations of CD3+ T cells in the colon and rectum and in the myenteric plexus of the small intestine were increased in patients with IBS or PI-IBS compared with normal controls.
“Additionally, increased concentrations of CD3+ T cells in the colon and rectum and in the myenteric plexus of the small intestine were increased in these patients compared with normal controls (36, 46, 57, 58, 89, 94, 133, 168, 174).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [89]
Some studies demonstrated an increase in activated mast cells in biopsies from specific regions of the GI tract (cecum and terminal ileum) but not from other regions, whereas other studies found activated mast cells in the descending colon.
“Notably, some studies demonstrated an increase in activated mast cells in biopsies from specific regions of the GI tract (i.e., cecum and terminal ileum) but not from other regions (e.g., ascending colon, descending colon, rectum) (89, 121, 187), whereas other studies have found activated mast cells in the descending colon (11, 13).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [89]
Several studies have demonstrated increased concentrations of activated mast cells in patients with IBS compared with controls.
“Several studies have demonstrated increased concentrations of activated mast cells in patients with IBS compared with controls (11, 13, 24, 46, 89, 94, 121, 187).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [89]
Concentrations of intestinal epithelial lymphocytes may be increased in the small intestine, colon, and rectum of patients with IBS or PI-IBS.
“The concentrations of intestinal epithelial lymphocytes (IELs) may be increased in the small intestine (73, 174, 185), colon, and rectum (36, 89) of patients with IBS or PI-IBS.”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [89]
Concentrations of cytotoxic CD8+ T cells may be elevated in the lamina propria of the colon of patients with IBS or PI-IBS, although this finding was disputed by others.
“Concentrations of cytotoxic CD8+ T cells, which comprise most of the intraepithelial T cell population (126) may also be elevated in the lamina propria of the colon of patients with IBS (46, 123) or PI-IBS (89) although this finding was disputed by others (36).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [89]
In patients with PI-IBS, activation of the GI immune system follows acute GI infection.
“The importance of the interaction between the intestinal microbiota and immune system in IBS patients is demonstrated by a few studies in patients with PI-IBS, indicating activation of the GI immune system following the acute GI infection (57, 58, 75, 89, 94, 124, 168, 170, 187)”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475 · see citing works
Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155 · see citing works
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024 · see citing works
Basic and clinical aspects of visceral hyperalgesia
Mayer, E. A., & Gebhart, G. F. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90086-8 · Cited by 920 · see citing works
Activation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833 · see citing works
The role of psychological and biological factors in postinfective gut dysfunction
Gwee, K.-A., Leong, Y.-L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., & Read, N. W. (1999) · Gut · doi:10.1136/gut.44.3.400 · Cited by 764 · see citing works
Macrophage activation by endogenous danger signals
Zhang, X., & Mosser, D. (2007) · The Journal of Pathology · doi:10.1002/path.2284 · Cited by 607 · see citing works
Berkes, J., Viswanathan, V. K., Savkovic, S. D., & Hecht, G. (2003) · Gut · doi:10.1136/gut.52.3.439 · Cited by 594 · see citing works
Neal, K. R., Hebden, J., & Spiller, R. (1997) · BMJ · doi:10.1136/bmj.314.7083.779 · Cited by 586 · see citing works
Dunlop, S. P., Jenkins, D., Neal, K. R., & Spiller, R. C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.028 · Cited by 583 · see citing works
Törnblom, H., Lindberg, G., Nyberg, B., & Veress, B. (2002) · Gastroenterology · doi:10.1053/gast.2002.37059 · Cited by 516 · see citing works
Increased mast cells in the irritable bowel syndrome
O’Sullivan, Clayton, Breslin, Harman, Bountra, Mclaren, & O’Morain (2000) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2000.00221.x · Cited by 480 · see citing works
Psychometric scores and persistence of irritable bowel after infectious diarrhoea
Gwee, K., Read, N. W., Graham, J. C., McKendrick, M. W., Collins, S. M., Marshall, J. S., & Walters, S. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90341-4 · Cited by 466 · see citing works
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448 · see citing works
Psychometric scores and persistence of irritable bowel after infectious diarrhoea
Ka, G., Graham, J. C., McKendrick, M. W., Collins, S. M., Marshall, J. S., Walters, S., & Read, N. W. (1996) · African journal of medical practice · Cited by 429 · see citing works
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study
Rodríguez, L. A. G., & Ruigómez, A. (1999) · British medical journal · doi:10.1136/bmj.318.7183.565 · Cited by 409 · see citing works
Dunlop, S. P., Jenkins, D., & Spiller, R. C. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07542.x · Cited by 359 · see citing works
Spiller, R. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00324-x · Cited by 353 · see citing works
Terminal ileal mucosal mast cells in irritable bowel syndrome
Weston, A. P., Biddle, W. L., Bhatia, P. S., & Miner, P. B. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303164 · Cited by 338 · see citing works
Irritable bowel syndrome—post salmonella infection
McKendrick, M. W., & Read, N. W. (1994) · Journal of Infection · doi:10.1016/s0163-4453(94)94871-2 · Cited by 320 · see citing works
Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2
Kong, W., McConalogue, K., Khitin, L. M., Hollenberg, M. D., Payan, D. G., Böhm, S. K., & Bunnett, N. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8884 · Cited by 318 · see citing works
Prognosis in post-infective irritable bowel syndrome: a six year follow up study
Neal, K. R., Barker, L., & Spiller, R. E. (2002) · Gut · doi:10.1136/gut.51.3.410 · Cited by 274 · see citing works
Rugtveit, J., Brandtzaeg, P., Halstensen, T. S., FAUSA, O., & Scott, H. (1994) · Gut · doi:10.1136/gut.35.5.669 · Cited by 266 · see citing works
Recent understanding of IBD pathogenesis: Implications for future therapies
Kucharzik, T. F., Maaser, C., Lügering, A., Kagnoff, M. F., Mayer, L., Targan, S. R., & Domschke, W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235827.21778.d5 · Cited by 254 · see citing works
Clinical and pathophysiological characteristics of acute-onset functional dyspepsia
Tack, J. F., Demedts, I., Dehondt, G., Caenepeel, P., Fischler, B., Zandecki, M., & Janssens, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33663 · Cited by 250 · see citing works
Symptomatic overlap between irritable bowel syndrome and microscopic colitis
Limsui, D., Pardi, D. S., Camilleri, M., Loftus, E. V., Kammer, P. P., Tremaine, W. J., & Sandborn, W. J. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20059 · Cited by 167 · see citing works
VERESS, B., Löfberg, R., & Bergman, L. (1995) · Gut · doi:10.1136/gut.36.6.880 · Cited by 163 · see citing works
Post‐infectious irritable bowel syndrome in patients with Shigella infection
Ji, S.-W., Park, H., LEE, D., Song, Y. G., Choi, J., & LEE, S. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03574.x · Cited by 158 · see citing works
Self-citationLymphocytic colitis: clinical features, treatment, and outcomes
Pardi, D. S., Ramnath, V. R., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07030.x · Cited by 157 · see citing works
Bjerke, K., Halstensen, T. S., Jahnsen, F., Pulford, K. A. F., & Brandtzaeg, P. (1993) · Gut · doi:10.1136/gut.34.10.1357 · Cited by 124 · see citing works
Mast cells in inflammatory conditions of the gastrointestinal tract.
Hiatt, R. B., & KATZ, L. (1962) · PubMed · Cited by 112 · see citing works
Park, C., Joo, Y., Choi, S. K., Rew, J. S., Kim, S. J., & Lee, M. C. (2003) · Journal of Korean Medical Science · doi:10.3346/jkms.2003.18.2.204 · Cited by 98 · see citing works
Motomura, Y., Ghia, J., Wang, H., Akiho, H., El–Sharkawy, R. T., Collins, M., Wan, Y., McLaughlin, J. T., & Khan, W. I. (2008) · Gut · doi:10.1136/gut.2007.129296 · Cited by 80 · see citing works
Li, Y., Yio, X., & Mayer, L. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.4.1079 · Cited by 71 · see citing works
5‐Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors
Tonini, M. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00716.x · Cited by 66 · see citing works
Effects of surgical manipulation of the intestine on peptide YY and its physiology
Imamura, M. (2002) · Peptides · doi:10.1016/s0196-9781(01)00618-0 · Cited by 50 · see citing works
[The development of irritable bowel syndrome after Shigella infection: 3 year follow-up study].
Kim, H. S., Kim, M. S., Ji, S. W., & Park, H. (2006) · PubMed · Cited by 43 · see citing works
Self-citationGastric emptying of liquid in children suffering from acute rotaviral gastroenteritis.
Bardhan, P. K., Salam, M. A., & Molla, A. M. (1992) · Gut · doi:10.1136/gut.33.1.26 · Cited by 33 · see citing works
Hausmann, M., Bataille, F., Spoettl, T., Schreiter, K., Falk, W., Schöelmerich, J., Herfarth, H. H., & Rogler, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1389 · Cited by 23 · see citing works
Imamura, M., Nakajima, H., Mikami, Y., & Yamauchi, H. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026620900259 · Cited by 14 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [39]Chadwick VS Chen W Shu D Paulus B Bethwait P Tie A Activation of the mucosal immune system in irritable bowel syndrome Gastroenterology 2002 122 1778 1783 12055584
Cited by
Sorted by citations
The role of mast cells in functional GI disorders
Wouters, M. M., Vicario, M., & Santos, J. (2016) · Gut · doi:10.1136/gutjnl-2015-309151 · Cited by 308 · see citing works
Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome
Barbara, G., Grover, M., Berčík, P., Corsetti, M., Ghoshal, U. C., Öhman, L., & Rajilić-Stojanović, M. D. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.011 · Cited by 283 · see citing works
Matricon, J., Méleine, M., Gelot, A., Piche, T., Dapoigny, M. C., Muller, E., & Ardid, D. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12080 · Cited by 216 · see citing works
Irritable bowel syndrome: Diagnosis and pathogenesis
El‐Salhy, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i37.5151 · Cited by 214 · see citing works
Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
Bennet, S., Öhman, L., & Simrén, M. (2015) · Gut and Liver · doi:10.5009/gnl14344 · Cited by 143 · see citing works
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115 · see citing works
Neuroanatomy of lower gastrointestinal pain disorders
Vermeulen, W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i4.1005 · Cited by 116 · see citing works
Recent developments in the pathophysiology of irritable bowel syndrome
El-Salhy, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7621 · Cited by 111 · see citing works
Diet in irritable bowel syndrome
El‐Salhy, M., & Gundersen, D. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0022-3 · Cited by 111 · see citing works
Inflammation in irritable bowel syndrome: Myth or new treatment target?
Sinagra, E., Pompei, G., Tomasello, G., Cappello, F., Morreale, G. C., Amvrosiadis, G., Rossi, F., Monte, A. I. L., Rizzo, A. G., & Raimondo, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2242 · Cited by 102 · see citing works
TLR ligands and butyrate increasePyyexpression through two distinct but inter-regulated pathways
Larraufie, P., Dore, J. M., Lapaque, N., & Blottière, H. M. (2016) · Cellular Microbiology · doi:10.1111/cmi.12648 · Cited by 99 · see citing works
Is irritable bowel syndrome an organic disorder?
El‐Salhy, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.384 · Cited by 95 · see citing works
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
Mamieva, Z. A., Poluektova, E. A., Свистушкин, В. М., Sobolev, V., Shifrin, O. S., Guarner, F., & Ivashkin, V. T. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i12.1204 · Cited by 85 · see citing works
Targeting the 5-HT3 receptor in the treatment of irritable bowel syndrome
Spiller, R. E. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.02.005 · Cited by 76 · see citing works
Shariati, A., Fallah, F., Pormohammad, A., Taghipour, A., Safari, H., Chirani, A. S., Sabour, S., Sani, M. A., & Azimi, T. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27828 · Cited by 71 · see citing works
The role of peptide YY in gastrointestinal diseases and disorders
El‐Salhy, M., Mazzawi, T. R. E., Gundersen, D., Hatlebakk, J. G., & Hausken, T. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1222 · Cited by 66 · see citing works
El‐Salhy, M., Gundersen, D., Østgaard, H. N., Lomholt-Beck, B., Hatlebakk, J. G., & Hausken, T. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1948-8 · Cited by 66 · see citing works
Shea‐Donohue, T., Stiltz, J. A., Zhao, A., & Notari, L. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0132-1 · Cited by 65 · see citing works
High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis
El‐Salhy, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i42.6070 · Cited by 64 · see citing works
Layunta, E., Buey, B., Mesonero, J. E., & Latorre, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.748254 · Cited by 67 · see citing works
Kumar, S., Ranjan, P., Mittal, B., & Ghoshal, U. C. (2012) · PubMed · Cited by 61 · see citing works
Post-infection Irritable Bowel Syndrome
Berumen, A., Edwinson, A. L., & Grover, M. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.02.007 · Cited by 60 · see citing works
Wei, L., Singh, R., & Ghoshal, U. C. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22008 · Cited by 65 · see citing works
Martin‐Viñas, J. J., & Quigley, E. M. M. (2016) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12379 · Cited by 57 · see citing works
High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome
Hod, K., Ringel‐Kulka, T., Martin, C. F., Maharshak, N., & Ringel, Y. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000327 · Cited by 53 · see citing works
Ishihara, S., Tada, Y., Fukuba, N., Oka, A., Kusunoki, R., Mishima, Y., Oshima, N., Moriyama, I., Yuki, T., Kawashima, K., et al. (2013) · Digestion · doi:10.1159/000350054 · Cited by 51 · see citing works
Abnormal rectal endocrine cells in patients with irritable bowel syndrome
El‐Salhy, M., Gundersen, D., Hatlebakk, J. G., Gilja, O. H., & Hausken, T. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.11.005 · Cited by 52 · see citing works
Grover, M., Camilleri, M., Smith, K., Linden, D. R., & Farrugia, G. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12304 · Cited by 48 · see citing works
Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review
Lupu, V. V., Ghiciuc, C. M., Ștefănescu, G., Mihai, C. M., Popp, A., Săsăran, M. O., Bozomitu, L. I., Stârcea, I. M., Răileanu, A. A., & Lupu, A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i21.3241 · Cited by 50 · see citing works
Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease
El‐Salhy, M., WENDELBO, I. H., & Gundersen, D. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1525 · Cited by 44 · see citing works
Mast Cells in Irritable Bowel Syndrome: A Systematic Review
Krammer, L., Sowa, A. S., & Lorentz, A. (2019) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-229 · Cited by 43 · see citing works
Silva, A. P. D., Nandasiri, S. D., Hewavisenthi, J., Manamperi, A., Ariyasinghe, M. P., Dassanayake, A. S., Jewell, D. P., & de Silva, H. J. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.666672 · Cited by 42 · see citing works
Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome
Pike, B. L., Paden, K. A., Alcala, A. N., Jaep, K. M., Gormley, R. P., Maue, A. C., Christmann, B. S., Elson, C. O., Riddle, M. S., & Porter, C. K. (2015) · Journal of Travel Medicine · doi:10.1111/jtm.12218 · Cited by 42 · see citing works
Endocrine cells in the ileum of patients with irritable bowel syndrome
El‐Salhy, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2383 · Cited by 41 · see citing works
Appetite, the enteroendocrine system, gastrointestinal disease and obesity
Crooks, B. J., Stamataki, N. S., & McLaughlin, J. T. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120006965 · Cited by 40 · see citing works
Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment
El‐Salhy, M., Hatlebakk, J. G., Gilja, O. H., & Hausken, T. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.888952 · Cited by 39 · see citing works
Schmulson, M. J., Bielsa, M. V., Carmona-Sánchez, R., Hernández, A., López‐Colombo, A., López‐Vidal, Y., Peláez‐Luna, M., Remes-Troche, J. M., Tamayo, J. L., & Valdovinos, M. A. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.01.001 · Cited by 38 · see citing works
Chromogranin A cell density in the rectum of patients with irritable bowel syndrome
El‐Salhy, M., Mazzawi, T. R. E., Gundersen, D., & Hausken, T. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1087 · Cited by 37 · see citing works
Post-infectious Irritable Bowel Syndrome: A Narrative Review
Sadeghı, A., Biglari, M., & Moghaddam, S. N. (2019) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2019.130 · Cited by 36 · see citing works
Gut microbiota and intestinal immunity—A crosstalk in irritable bowel syndrome
Chen, Y., Feng, S., Li, Y., Zhang, C., Chao, G., & Zhang, S. (2024) · Immunology · doi:10.1111/imm.13749 · Cited by 36 · see citing works
Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome
El‐Salhy, M., WENDELBO, I. H., & Gundersen, D. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1325 · Cited by 33 · see citing works
Role of gut pathogens in development of irritable bowel syndrome.
Grover, M. (2014) · Europe PMC (PubMed Central) · Cited by 31 · see citing works
Gong, Z., Chen, Y., Zhang, R., Wang, Y., Guo, Y. H., Yang, Q., Zhang, H., Dong, Y. J., Weng, X., Gao, S., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010456 · Cited by 30 · see citing works
El‐Salhy, M., Hausken, T., Gilja, O. H., & Hatlebakk, J. G. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1269601 · Cited by 29 · see citing works
Schmulson, M., Bielsa, M. V., Carmona-Sánchez, R., Hernández, A., López-Colombo, A., López Vidal, Y., Peláez-Luna, M., Remes-Troche, J. M., Tamayo, J. L., & Valdovinos, M. A. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.01.004 · Cited by 29 · see citing works
“Casos y controles Sujetos sometidos a prueba de aliento EII vs Roma I SII (SII-E, SII-D) 78 vs 296 (120, 111) PAL, cuestionario de síntomas Metano+: > gravedad de síntomas en SII-E (p < 0.”
BackgroundDecreased Basal and Postprandial Plasma Serotonin Levels in Patients With Functional Dyspepsia
Cheung, C., Lee, Y. Y., Chan, Y., Cheong, P. K., Law, W. T., Lee, S. F., Sung, J. J. �., Chan, F. K. L., & Wu, J. C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.03.026 · Cited by 28 · see citing works
Self-citationEndocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome
El‐Salhy, M. (2014) · World Journal of Gastrointestinal Endoscopy · doi:10.4253/wjge.v6.i5.176 · Cited by 27 · see citing works
Human enteroendocrine cell responses to infection with Chlamydia trachomatis: a microarray study
Dlugosz, A., Muschiol, S., Zakikhany, K., Assadi, G., D’Amato, M., & Lindberg, G. (2014) · Gut Pathogens · doi:10.1186/1757-4749-6-24 · Cited by 25 · see citing works
Enterochromaffin cell hyperplasia in the gut: Factors, mechanism and therapeutic clues
Qin, H., Wong, H. L. X., Zang, K., Li, X., & Bian, Z. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116886 · Cited by 25 · see citing works
Interaction between gut microbiota and immunity in health and intestinal disease
Wang, Q., Meng, Q., Chen, Y., Liu, Y., Li, X., Zhou, J., Ma, Y., Yu, Z., & Chen, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1673852 · Cited by 27 · see citing works
Stomach antral endocrine cells in patients with irritable bowel syndrome
El‐Salhy, M., Gilja, O. H., Hatlebakk, J. G., & Hausken, T. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1887 · Cited by 22 · see citing works
El‐Salhy, M., & Gilja, O. H. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0643-4 · Cited by 23 · see citing works
Chang, H.-C., Yen, A. M.-F., Fann, J. C. ‐., Chiu, S. Y., Liao, C., Chen, H.-H., Yang, K.-C., Chen, L. S., & Lin, Y.-M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.575 · Cited by 21 · see citing works
El‐Salhy, M., Gundersen, D., Hatlebakk, J. G., & Hausken, T. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1385 · Cited by 19 · see citing works
Lu, S., Chen, Y., Guo, H., Liu, Z., Du, Y., & Duan, L. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.07.011 · Cited by 18 · see citing works
Recent advances in the diagnosis of irritable bowel syndrome
El‐Salhy, M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1067138 · Cited by 18 · see citing works
Irritable bowel syndrome – Diarrhoea
Wald, A. M. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.11.002 · Cited by 17 · see citing works
Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
El‐Salhy, M., Gilja, O. H., & Hausken, T. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2472 · Cited by 17 · see citing works
Imbrea, A.-M., Balta, I., Dumitrescu, G., McCleery, D., Peț, I., Iancu, T., Ştef, L., Corcionivoschi, N., & Liliana, P. (2024) · Applied Sciences · doi:10.3390/app14083373 · Cited by 15 · see citing works
Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome
Mazzawi, T. R. E., & El‐Salhy, M. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3491 · Cited by 15 · see citing works
El‐Salhy, M., Mazzawi, T. R. E., Gundersen, D., Hatlebakk, J. G., & Hausken, T. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-391 · Cited by 14 · see citing works
Irritable Bowel Syndrome in Terms of Changes in the Microbiota
Ivashkin, V. T., & Zolnikova, O. Y. (2019) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2019-29-1-84-92 · Cited by 13 · see citing works
Diet and Irritable Bowel Syndrome, with a Focus on Appetite-Regulating Gut Hormones
El‐Salhy, M., Gundersen, D., Hatlebakk, J. G., & Hausken, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407869-7.00001-5 · Cited by 9 · see citing works
Environmental pesticide exposure and the risk of irritable bowel syndrome: A case-control study
Rueda‐Ruzafa, L., Román, P., Cardona, D., Requena, M., Ropero‐Padilla, C., & Alarcón, R. (2023) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2023.104076 · Cited by 8 · see citing works
Martínez, C., Lasitschka, F., Thöni, C., Wohlfarth, C., Braun, A., Granzow, M., Röth, R., Dizdar, V., Rappold, G., Hausken, T., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13868 · Cited by 7 · see citing works
Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic Implications
Crisan, I. M., & Dumitrascu, D. L. (2014) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-269 · Cited by 7 · see citing works
Gregersen, Valeur, J., Lillestøl, Frøyland, Araújo, Lied, G. A., & Berstad, A. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s18349 · Cited by 7 · see citing works
Dlugosz, A., Zakikhany, K., Muschiol, S., Hultenby, K. R., & Lindberg, G. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01765.x · Cited by 6 · see citing works
Friesen, H. J., Singh, M., Singh, V., Schurman, J. V., & Friesen, C. A. (2021) · Gastrointestinal Disorders · doi:10.3390/gidisord3040016 · Cited by 5 · see citing works
Dizdar, V., Hausken, T., Lærum, O. D., Gilja, O. H., Langeland, N., & Hanevik, K. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy690 · Cited by 4 · see citing works
Post-infectious irritable bowel syndrome: renaissance time?
Gaus, O. V., Livzan, M. A., & Александровна, Г. Д. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-35-23-28 · Cited by 3 · see citing works
Inflammation as a Potential Therapeutic Target in IBS
Chira, A., Chira, R. I., & Dumitrascu, D. L. (2016) · InTech eBooks · doi:10.5772/66193
Bai, X., Zhou, X., Yu, Y., Liu, H., Cheng, L., Yang, B. K., & Liu, D. (2017) · Internal Medicine Open Access · doi:10.4172/2165-8048.1000253 · Cited by 1 · see citing works
Pathophysiology and Diagnosis of Irritable Bowel Syndrome
Kang, H., & Jung, H.-K. (2011) · The Korean Journal of Internal Medicine · Cited by 1 · see citing works
Ткач, С. М., & Mirzabayeva, N. M. (2019) · Modern Gastroenterology · doi:10.30978/mg-2019-1-93 · Cited by 1 · see citing works
Villanacci, V., Mourin, A., & Salviato, T. (2018) · Springer eBooks · doi:10.1007/978-3-319-89503-1_14 · Cited by 1 · see citing works
From Discomfort to Delight: Diet's Impact on IBS-D
Islam, S. M. S. (2023) · Journal of Clinical Medical Research · doi:10.46889/jcmr.2023.4303
Halliez, M. C. M. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27133 · Cited by 1 · see citing works
[Irritable bowel syndrome: a functional disorder?].
Man, F., & Fernández, L. M. B. (2013) · PubMed
Nelson, E. (2012) · Swinburne figshare (Swinburne University of Technology) · doi:10.25916/sut.26271883
Sinagra, E., Rossi, F., Raimondo, D., Pietra, C., Pisciotto, P., Pompei, G., Tomasello, G., Cappello, F., Morreale, G. C., Amvrosiadis, G., et al. (2016)
Guilarte, M. (2014) · TDX (Tesis Doctorals en Xarxa)
Infections Associated With Irritable Bowel Syndrome
Gurunathan, S. V., & Grover, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54843-4.00007-6
Gaus, O. V., Fedorenko, A. S., & Судакова, А. Н. (2025) · Medical alphabet · doi:10.33667/2078-5631-2024-34-36-41
- Authors
- Kim, H. S., Lim, J. H., Park, H., & Lee, S. I.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Park, Hyojin
- Venue
- Yonsei Medical Journal
- Publisher
- XMLink
- Published
- 2010
- Volume
- 51
- Issue
- 1
- Pages
- 45
- ISSN
- 0513-5796 (ISSN-L)
- PMC
- PMC2799963
- OpenAlex
- W2134456599
- Cited by
- 85
- References
- 40
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 7 · 2015: 7 · 2014: 18 · 2013: 9 · 2012: 9
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Yonsei Medical Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Health Sciences › Medicine › Epidemiology › Microscopic Colitis
- Keywords
- post-infectious irritable bowel syndrome, shigellosis, enterochromaffin cells, serotonin, peptide YY, intraepithelial lymphocytes, lamina propria lymphocytes, mast cells, macrophages, calprotectin, colonic mucosa, diarrhea-predominant irritable bowel syndrome
- MeSH terms
- CD68 Molecule, Adult, Colonoscopy, Dysentery, Bacillary, Enterochromaffin Cells, Female, Humans, Immunohistochemistry, Intestinal Mucosa, Macrophages, Male, Mast Cells, Rectum, Serotonin, Colon, Sigmoid, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Case-Control Studies, CD8-Positive T-Lymphocytes, Peptide YY, Irritable Bowel Syndrome, Colon, Descending
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review